Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dalton Pharma Services has successfully received a ‘Compliant’ rating from the Health Products and Food Branch Inspectorate of Health Canada.
read more
Tuesday, September 11, 2018
As a part of a 10 million dollar facility and capital expansion, Dalton Pharma Services has invested in a fully automated Sterile Liquid Filling System that will become operational in Q1 of 2019.
read more
Wednesday, January 28, 2015
Dalton Pharma Services today announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing.
read more
Monday, November 26, 2018
Dalton Pharma announced a drug development and manufacturing services agreement with ExCellThera, a biotechnology company focused on delivering molecules and bioengineering solutions.
read more
Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider, has announced the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.
read more
Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm.
read more
Dalton Pharma Services announced the signing of a drug development and manufacturing services agreement with Arch Biopartners.
read more
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Oryn Therapeutics.
read more
Tuesday, January 17, 2017
Dalton Pharma Services has announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in Gaithersburg, Maryland, USA. Cerium is dedicated to the ...
read more
Wednesday, December 15, 2021
Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and ...
read more
The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients.
read more
Berkeley Lights announced a program with global pharmaceutical company Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.
read more
Daiichi Sankyo Company and Boston Pharmaceuticals, Inc. have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.
read more
Daiichi Sankyo and Glycotope GmbH have entered into an exclusive worldwide licensing agreement to develop an ADC.
read more
Wednesday, October 26, 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC (Inspirion) announced today that the companies have entered into a strategic collaboration agreement in the U.S. to commercialize FDA-approved MorphaBond™ (morphine sulfate) extended-release ...
read more